OmanDocSign in

Curriculum · Metabolic and Endocrine and Diabetes Mellitus

Hypertriglyceridaemia

Causes and risk

Secondary causes of hypertriglyceridemia are ruled out first:

How it is treated

The base of care is a healthy lifestyle and strong glycemic control. For patients with a raised fasting triglyceride level, treat with a healthy diet, weight reduction, exercise and a statin. Consider a fibrate or fish oil in addition to statins. Once the triglyceride levels are brought down you may consider stopping the fenofibrate.

The level at which drug treatment begins is given as a fasting triglyceride of 5.7 mmol/L in one place and, as the indication to pharmacologically treat TGL, a level of 5.65 in another, with fenofibrate named as the drug to start.

The national guideline gives its advice on either side of 5.7 mmol/l. Below 5.7 mmol/l the treatment is a healthy diet, weight reduction, exercise and consider adding a statin. Above 5.7 mmol/l it is a healthy diet, weight reduction, exercise and a statin, with a fibrate or fish oil considered in addition to the statin. So the statin is on both sides of the line, to consider below it and to give with the diet, weight reduction and exercise above it, and it is the fibrate or the fish oil that is added once the level goes above it.

Once therapy has started the monitoring is fixed. The lipid profile is repeated 3 months after starting therapy, and the dose is adjusted or another drug added if targets are not achieved. Liver function tests are done before initiating the therapy, then 3 months after starting treatment and at 12 months, but not again unless clinically indicated. Creatinine kinase is not measured at baseline at all; it is measured only if the patient complains of muscle pain, and the statin is stopped if the CK level is more than 5 times the upper reference range.

The statin itself is used with caution or stopped outright in three situations. If the creatinine clearance is less than 30 ml/min, use the statin with caution. In the preconception period, in pregnancy or in breastfeeding, stop the statin. If unexplained peripheral neuropathy develops, stop the statin and seek specialist advice.